Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020-Reference-Cited by-同舟云学术

Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020

Published:2023-07-03 Issue:1 Volume:330 Page:80
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Aggarwal Rahul¹,Chiu Nicholas²,Libby Peter¹,Boden William E.³,Bhatt Deepak L.⁴

Affiliation:

1. Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts

2. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts

3. VA Boston Healthcare System, Boston University School of Medicine, Boston, Massachusetts

4. Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, New York

Abstract

This study uses National Health and Nutrition Examination Survey data to examine lipid control among adults in the US with coronary artery disease from January 2015 to March 2020.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2806668/jama_aggarwal_2023_ld_230038_1687532970.42155.pdf

Reference6 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Grundy;Circulation,2019

2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.;Mach;Eur Heart J,2020

3. Trends in lipid concentrations and lipid control among US adults, 2007-2018.;Aggarwal;JAMA,2022

4. Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: insights from a prospective longitudinal cohort study.;Arnold;Diabetes Obes Metab,2023

5. Contemporary national patterns of eligibility and use of novel lipid-lowering therapies in the United States.;Shen;J Am Heart Assoc,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherogenic lipid profile in patients with statin treatment after acute coronary syndrome: a real-world analysis from Chinese cardiovascular association database;Lipids in Health and Disease;2024-08-28

2. Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease;American Journal of Preventive Cardiology;2024-06

3. Hyperlipidemia-Attributed Deaths in the U.S. in 2018–2021;American Journal of Preventive Medicine;2024-06

4. Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024;Medical Clinics of North America;2024-05

5. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association;Circulation;2024-02-20